Clinical Trials Logo

Clinical Trial Details — Status: Not yet recruiting

Administrative data

NCT number NCT05436119
Other study ID # GrowBaby/Molina PIP 2022
Secondary ID
Status Not yet recruiting
Phase
First received
Last updated
Start date July 2022
Est. completion date October 2023

Study information

Verified date June 2022
Source GrowBaby Life Project
Contact Leslie P Stone, MD
Phone 541-414-5146
Email lstonemd@growbabyhealth.com
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

Preterm birth (PTB) rates in the US are among the highest in wealthy nations across the globe, and they are particularly high in our most socio-economically disadvantaged populations. PTB increases lifelong morbidity and mortality at significant economic cost. In addition to neonates born too early, small for gestational infants predict the greatest risk for chronic disease in the neonate (F1 generation) through adulthood. Single lifestyle, nutrient, or medical interventions intended to reduce PTB have produced mixed results, but combined micronutrient interventions appear more successful. The investigators experienced a reduced preterm birth rate and combined preeclampsia, gestational diabetes and small for gestational age rate in a 50% Medicaid population by providing targeted micro/macronutrient, genomic and lifestyle evaluation with personalized intervention in a trimester-by-trimester group educational setting (1). The model requires validation in more diverse populations. This study will be applied in a 100% Medicaid population with greater ethnic diversity. Participation will be voluntary, offered to all pregnant participants enrolling at 18 weeks gestation or earlier with the comparator group being those participants who decline the intervention. The study population will receive targeted biomarker evaluation including serum 25-OH D, zinc and carnitine levels, dried blood spot omega 3 fatty acids and select gene variant analysis. Virtual group nutrition and lifestyle education visits conducted by the nutritionist cluster participants in the same trimester allowing for personalization of the nutrition and lifestyle plan based on the data collected and adapted to the specific needs of the trimester. Each study participant will receive individualized nutrient supplementation and probiotic supplementation. Anticipated performance improvement endpoints are significant reduction of preterm birth and combined incidence of preeclampsia, gestational diabetes, small for gestational age, neonatal morbidities and related health care expenses. The investigators will explore gene variants' role in directing nutrition, lifestyle and toxic exposure interventions and in predicting adverse maternal and neonatal outcomes.


Description:

Hypothesis: • Diet and lifestyle education with diet and lifestyle modification will significantly decrease the incidence of preterm birth (PTB). Secondary Hypothesis: • Diet and lifestyle education and modification refined by limited genomics and nutrient biomarkers will significantly decrease the incidence of preeclampsia (preE), gestational diabetes mellitus (GDM), small for gestational age (SGA) and large for gestational age (LGA) neonates, and neonatal hospitalizations within the first 2 weeks of life. Exploratory Hypotheses: - A gene variant pattern will emerge that predicts PTB. - A gene variant pattern will emerge that predicts preE, GDM, SGA, and LGA. Goals: - Ascertain PTB rates for both intervention and non-intervention groups. - Ascertain preE, GDM, SGA, LGA, and neonatal hospitalization rates for both groups. - Correlate diet and lifestyle education and modification refined by limited genomics and micronutrient biomarkers with reduced primary and secondary outcomes. - Reduce related net healthcare costs. Methods: • Prospective longitudinal observational cohort with nested case-control study. Relevance: - Determine whether diet and lifestyle education and modification refined by trimester and by limited genomics and micronutrient biomarkers applied to a 100% Medicaid population is associated with reduced rates of PTB, preE, GDM, SGA, LGA, and neonatal hospitalizations. - Determine whether the reduction in pregnancy and neonatal morbidities is associated with a reduction in related net health care costs. - Explore predictive capability of limited genomics panel in a 100% Medicaid population.


Recruitment information / eligibility

Status Not yet recruiting
Enrollment 200
Est. completion date October 2023
Est. primary completion date July 2023
Accepts healthy volunteers
Gender Female
Age group N/A and older
Eligibility Inclusion Criteria: - pregnant - gestational age < 19 weeks at time of enrollment - Health care coverage through Molina Health of Nevada MCO - Residing in the state of Nevada - Signed consent Exclusion Criteria: - Not pregnant - Gestational age > 19 weeks at time of enrollment - Health care coverage not through Molina - Living outside the state of Nevada - No signed consent or unable to give informed consent

Study Design


Intervention

Dietary Supplement:
GrowBaby
Virtual group educational visits will cluster women in the same trimester of pregnancy teaching trimester-specific diet and lifestyle modification, further customized to the individual using limited micronutrient and gene variant analysis. Each woman will receive base multi-nutrient and probiotic supplementation with customization if identified needs cannot be met with diet and lifestyle modification alone.

Locations

Country Name City State
United States Women's Health Associates of Nevada (WHAsN) Las Vegas Nevada

Sponsors (3)

Lead Sponsor Collaborator
GrowBaby Life Project Metagenics, Inc., OmegaQuant, LLC

Country where clinical trial is conducted

United States, 

References & Publications (1)

Stone LP, Stone PM, Rydbom EA, Stone LA, Stone TE, Wilkens LE, Reynolds K. Customized nutritional enhancement for pregnant women appears to lower incidence of certain common maternal and neonatal complications: an observational study. Glob Adv Health Med. 2014 Nov;3(6):50-5. doi: 10.7453/gahmj.2014.053. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Other Gene variant pattern analysis Evaluating association of gene variant patterns with primary and secondary outcomes in each group, and in the nested case control subset At 20 weeks EGA
Primary Preterm Birth < 37 weeks EGA Evaluating the percentage of preterm birth in each group, further divided by delivery < 28 weeks, 28 to <= 32 weeks, 32 to <= 36 weeks, and 36 to <= 37 weeks. At conclusion of pregnancy
Secondary Preeclampsia Evaluating the percentage of preeclampsia, condition defined by ACOG standards At conclusion of pregnancy
Secondary Gestational diabetes mellitus(GDM) Evaluating the percentage of GDM in each group, condition defined by ACOG standards At conclusion of pregnancy
Secondary Small for gestational age infant (SGA) Evaluating the percentage of SGA in each group, condition defined by APP standards. At conclusion of pregnancy
Secondary Large for gestational age infant (LGA) Evaluating the percentage of LGA in each group, condition defined by APP standards. At conclusion of pregnancy
Secondary Neonatal hospitalization within 2 weeks of delivery Evaluating the percentage of neonatal hospitalization within 2 weeks of delivery in each group 8 weeks postpartum
See also
  Status Clinical Trial Phase
Active, not recruiting NCT05048550 - Babies in Glasses; a Feasibility Study. N/A
Active, not recruiting NCT03655639 - Local Version of the Multi-center PREVENT Study Evaluating Cardio-respiratory Instability in Premature Infants
Enrolling by invitation NCT05542108 - Adding Motion to Contact: A New Model for Low-cost Family Centered Very-early Onset Intervention in Very Preterm-born Infants N/A
Completed NCT03680157 - Comparing Rater Reliability of Familiar Practitioners to Blinded Coders
Completed NCT03337659 - A Cluster Randomized Controlled Trial of FICare at 18 Months N/A
Completed NCT03649932 - Enteral L Citrulline Supplementation in Preterm Infants - Safety, Efficacy and Dosing Phase 1
Completed NCT03251729 - Cerclage On LOw Risk Singletons: Cervical Cerclage for Prevention of Spontaneous Preterm Birth in Low Risk Singleton Pregnancies With Short Cervix Phase 4
Not yet recruiting NCT05039918 - Neonatal Experience of Social Touch N/A
Not yet recruiting NCT03418012 - Prevention of sPTB With Early Cervical Pessary Treatment in Women at High Risk for PTB N/A
Not yet recruiting NCT03418311 - Cervical Pessary Treatment for Prevention of s PTB in Twin Pregnancies on Children`s Long-Term Outcome N/A
Not yet recruiting NCT02880696 - Perception of Temporal Regularity in Tactile Stimulation: a Diffuse Correlation Spectroscopy Study in Preterm Neonates N/A
Completed NCT02913495 - Vaginal Versus Intramuscular Progesterone for the Prevention of Recurrent Preterm Birth Phase 4
Completed NCT02952950 - Is it Possible to Prolong the Duration of Breastfeeding in Premature Infants? a Prospectivt Study N/A
Completed NCT02661360 - Effects of Swaddling on Infants During Feeding N/A
Completed NCT02879799 - Family Integrated Care (FICare) in Level II NICUs N/A
Completed NCT02743572 - Iron-fortified Parenteral Nutrition in the Prevention and Treatment of Anemia in Premature Infants N/A
Completed NCT01352234 - Comparison of Doses of Acetylsalicylic Acid in Women With Previous History of Preeclampsia Phase 4
Completed NCT01163188 - Social Adjustment and Quality of Life After Very Preterm Birth N/A
Terminated NCT00675753 - Three Interacting Single Nucleotide Polymorphisms (SNPs) and the Risk of Preterm Birth in Black Families N/A
Terminated NCT00179972 - Evaluation of Pulse Oximetry Sensors in Neonates N/A